<?xml version='1.0' encoding='UTF-8' ?>
<html id="data-uuid-f5e8d0cc92c14a9998958ec28adc100d" data-uuid="f5e8d0cc92c14a9998958ec28adc100d" xmlns="http://www.w3.org/1999/xhtml">
    <head>
        <title>6.4 Platelets and Blood Clotting</title>
        <meta charset="utf-8" />
        <link type="text/css" rel="stylesheet" media="screen" href="../../assets/css/main.css" />
    <link type="text/css" rel="stylesheet" href="../../assets/fonts/fonts.css" /><link type="text/css" rel="stylesheet" href="../../assets/css/epub_main.css" /><script src="../../assets/js/habitat_platform.js"></script></head>
    <body class="chapter06 card-chapter-reader">
        <header id="data-uuid-4e63c9f5d85342ea84b7c2911e1f67f0" data-uuid="4e63c9f5d85342ea84b7c2911e1f67f0">
            <h1 id="data-uuid-3a9402e7f7d7451193f147ce19f5116f" data-uuid="3a9402e7f7d7451193f147ce19f5116f"><span class="enum">6.4</span> Platelets and Blood Clotting</h1>
        </header>
        <section id="data-uuid-e6658150143f43eb9c1ff8c6aadbc052" data-uuid="e6658150143f43eb9c1ff8c6aadbc052" class="sidenote sidenote-learning">
            <h4 id="data-uuid-e3b88c269e564d2fac5b16189926036b" data-uuid="e3b88c269e564d2fac5b16189926036b">Learning Outcomes</h4>
            <p id="data-uuid-fa40a59cf2b0432aab14cc550b382635" data-uuid="fa40a59cf2b0432aab14cc550b382635">Upon completion of this section, you should be able to</p>
            <ol id="data-uuid-7345a30f095b4178b4fb561a391bc032" data-uuid="7345a30f095b4178b4fb561a391bc032" class="list-bold">
                <li id="data-uuid-c8b4ae4de78546a28f9ce54092c06d3d" data-uuid="c8b4ae4de78546a28f9ce54092c06d3d">
                    <p id="data-uuid-a61b3b7cca984c88922c36570d763d42" data-uuid="a61b3b7cca984c88922c36570d763d42">Explain how blood clotting relates to homeostasis.</p>
                </li>
                <li id="data-uuid-2bf0db7d94c846f2b6977e6892793e87" data-uuid="2bf0db7d94c846f2b6977e6892793e87">
                    <p id="data-uuid-315a210350a64ef781f44c453e4dcbcb" data-uuid="315a210350a64ef781f44c453e4dcbcb">List the steps in the formation of a blood clot.</p>
                </li>
                <li id="data-uuid-e70a3e3ddc2c470cb3000b4f68ce5c06" data-uuid="e70a3e3ddc2c470cb3000b4f68ce5c06">
                    <p id="data-uuid-a32c07fc6b15427397d652b6a10fce8a" data-uuid="a32c07fc6b15427397d652b6a10fce8a">Describe disorders associated with blood clotting.</p>
                </li>
            </ol>
        </section>
        <p id="data-uuid-13f4fa07d850464c9b1b28612cdc99c1" data-uuid="13f4fa07d850464c9b1b28612cdc99c1"><a href="../glossary.xhtml#key-platelet-thrombocyte"><dfn title="platelet (thrombocyte)">Platelets <em>(also called </em>thrombocytes<em>)</em></dfn></a> result from the fragmentation of large cells, called <a href="../glossary.xhtml#key-megakaryocyte"><dfn title="megakaryocyte">megakaryocytes</dfn></a><b>,</b> in the red bone marrow. Platelets are produced at a rate of 200 billion a day, and the blood contains 130,000 to 400,000 per <span class="text-serif">μl</span>. These formed elements are involved in the process of blood <a href="../glossary.xhtml#key-clotting"><dfn title="clotting">clotting</dfn></a><b>,</b> or <a href="../glossary.xhtml#key-coagulation"><dfn title="coagulation">coagulation</dfn></a><b>.</b> Also involved are the plasma proteins <a href="../glossary.xhtml#key-prothrombin"><dfn title="prothrombin">prothrombin</dfn></a> and <a href="../glossary.xhtml#key-fibrinogen"><dfn title="fibrinogen">fibrinogen</dfn></a><b>,</b> manufactured in the liver and deposited in the blood. Vitamin K is necessary to the production of prothrombin.</p>
        <h2 id="data-uuid-f8753ad026f94d29a84404532da19107" data-uuid="f8753ad026f94d29a84404532da19107">Blood Clotting</h2>
        <p id="data-uuid-ec634adf0bc84fef8daf0daf60c74fe3" data-uuid="ec634adf0bc84fef8daf0daf60c74fe3">The blood-clotting process helps the body maintain homeostasis in the cardiovascular system by ensuring that the plasma and formed elements remain within the blood vessels. At least 12 clotting factors and calcium ions (Ca<sup>2+</sup>) participate in the formation of a blood clot.</p>
        <p id="data-uuid-94fd91e8dc9b409eb7a8b17bbba80f6e" data-uuid="94fd91e8dc9b409eb7a8b17bbba80f6e">When a blood vessel in the body is damaged, platelets clump at the site of the puncture and partially seal the leak (<a href="ch06_reader_4.xhtml#data-uuid-add70a87ad9b49cd8ec95684da3963b5" class="link-inline">Fig. 6.7</a>). Platelets and the injured tissues release a clotting factor called prothrombin activator, which converts prothrombin in the plasma to <a href="../glossary.xhtml#key-thrombin"><dfn title="thrombin">thrombin</dfn></a><b>.</b> This reaction requires calcium ions (Ca<sup>2+</sup>). Thrombin, in turn, acts as an enzyme that severs two short amino acid chains from a fibrinogen molecule, one of the proteins in plasma. These activated fragments then join end to end, forming long threads of <a href="../glossary.xhtml#key-fibrin"><dfn title="fibrin">fibrin</dfn></a>.</p>
        <figure id="data-uuid-add70a87ad9b49cd8ec95684da3963b5" data-uuid="add70a87ad9b49cd8ec95684da3963b5">
            <img src="../../img/chapter06/ch06_figure_text_07.png" id="data-uuid-2cdcc0c44c604b669b66ff612f7ae125" data-uuid="2cdcc0c44c604b669b66ff612f7ae125" class="text-image ch06_figure_text_07" alt="" />
            <figcaption>
                <span class="figure-number">
                    <span class="figure-designation">Figure</span>
                    <span class="figure-enumeration">6.7</span>
                </span>
                <span class="caption-title">The steps in the formation of a blood clot.</span>
                <span class="caption-body"><b>a.</b> Platelets and damaged tissue cells release prothrombin activator, which acts on prothrombin in the presence of Ca<sup>2+</sup> (calcium ions) to produce thrombin. Thrombin acts on fibrinogen in the presence of Ca<sup>2+</sup> to form fibrin threads. <b>b.</b> A scanning electron micrograph of a blood clot shows red blood cells caught in the fibrin threads.</span>
            </figcaption>
        </figure>
        <p id="data-uuid-bc6ce081b1cf4f868818c6c40aa124bf" data-uuid="bc6ce081b1cf4f868818c6c40aa124bf">Fibrin threads wind around the platelet plug in the damaged area of the blood vessel and provide the framework for the clot. Red blood cells trapped within the fibrin threads make the clot appear red. A fibrin clot is temporary. Once blood vessel repair starts, an enzyme called <i>plasmin </i>destroys the fibrin network, so that tissue cells can grow.</p>
        <p id="data-uuid-8d71d0c4b67b49adbc057926aef070e7" data-uuid="8d71d0c4b67b49adbc057926aef070e7">After the blood clots, a yellowish fluid called <i>serum</i> escapes from the clot. It contains all the components of plasma except fibrinogen and prothrombin.</p>
        <section id="data-uuid-0ecfaccfd38e422fa730524e8b9823ba" data-uuid="0ecfaccfd38e422fa730524e8b9823ba" class="sidenote sidenote-health">
            <h4 id="data-uuid-f5077f1d662d40529becbb549e1bf305" data-uuid="f5077f1d662d40529becbb549e1bf305">Biology Matters<img src="../../assets/img/icon9.png" id="data-uuid-6f1299749de944caae8712f6f4aa37b4" data-uuid="6f1299749de944caae8712f6f4aa37b4" class="health-icon inline" /><span class="title-case">Health</span></h4>
            <h4 id="data-uuid-0fb80b82683248d09cecce16a3564701" data-uuid="0fb80b82683248d09cecce16a3564701">Aspirin and Heart Disease</h4>
            <p id="data-uuid-09d17f5586c74771941613096edd18a2" data-uuid="09d17f5586c74771941613096edd18a2">Aspirin (<a href="ch06_reader_4.xhtml#data-uuid-db010c0310074724b0e07266892dba19" class="link-inline">Fig. 6A</a>), acetylsalicylic acid, has long been recognized as treatment for pain. However, low-dose use of aspirin is now known to reduce the chances of some forms of heart disease, including strokes and heart attacks. It does this by interfering with the normal cascade of events in the blood-clotting pathway, as shown in <a href="ch06_reader_4.xhtml#data-uuid-add70a87ad9b49cd8ec95684da3963b5" class="link-inline">Figure 6.7<i>a</i></a>.</p>
            <figure id="data-uuid-db010c0310074724b0e07266892dba19" data-uuid="db010c0310074724b0e07266892dba19" class="width-center">
                <img src="../../img/chapter06/ch06_figure_text_06b.png" id="data-uuid-86b153954e0149c9840ff9c475e378b7" data-uuid="86b153954e0149c9840ff9c475e378b7" class="text-image ch06_figure_text_06b" alt="" />
                <figcaption>
                    <span class="figure-number">
                        <span class="figure-designation">Figure</span>
                        <span class="figure-enumeration">6A</span>
                    </span>
                    <span class="caption-title">Aspirin and heart disease.</span>
                    <span class="caption-body">Low doses of aspirin may prevent some forms of heart disease.</span>
                </figcaption>
            </figure>
            <p id="data-uuid-4e6d7ba78bbc4014a7c1789d67f9065b" data-uuid="4e6d7ba78bbc4014a7c1789d67f9065b">When platelets (thrombocytes)  are located in the blood, they exist as individual cell fragments. However, following an injury, the damaged cells release chemicals that cause the platelets to become “sticky” and clump together into larger groups called aggregates.</p>
            <p id="data-uuid-980da3c742ba495b98289a025190bb27" data-uuid="980da3c742ba495b98289a025190bb27">The conversion of platelets to the stickier version is due to a chemical called thromboxane. Thromboxane is released by a platelet in response to an injury or a wound in the area. As platelets aggregate, they release more thromboxane. This is an example of a positive feedback mechanism (see <a href="../chapter04/ch04_reader_8.xhtml#data-uuid-df18a979bbaf484aa1bf52c66e982063" class="link-inline">section 4.8</a>), and it allows for a rapid response to an injury, thus reducing the loss of blood.</p>
            <p id="data-uuid-53bdfce250be4862b12c0778bddce028" data-uuid="53bdfce250be4862b12c0778bddce028">A problem occurs when platelets start to stick together in the absence of a wound. These unintended clots can form blockages in the heart and brain, causing heart attacks and strokes. Aspirin inhibits the activity of thromboxane, effectively making the platelets less likely to stick together. Several studies have indicated that the use of aspirin by individuals with heart disease, such as atherosclerosis, reduces the chances of a heart attack or stroke.</p>
            <p id="data-uuid-960fcee1751a4451884475d75ab9035f" data-uuid="960fcee1751a4451884475d75ab9035f">It is important to note that the actual dosage of aspirin that produces this effect has not been conclusively determined by the medical community, although most agree that doses around 75–80 milligrams (mg) per day are sufficient. There is no evidence that higher doses produce an increased effect and, in fact, can cause side effects such as ulcers and abdominal bleeding. While many drugstores sell low-dose aspirin (81-mg “baby” aspirin) over the counter, it is highly recommended that you consult with your physician before taking a daily dose of aspirin.</p>
            <h5 id="data-uuid-a66735e6499548a1a2e39e26bc832fb8" data-uuid="a66735e6499548a1a2e39e26bc832fb8" class="orange-h5">Questions to Consider</h5>
            <ol id="data-uuid-bdb612be6647405c979835ed5a454c61" data-uuid="bdb612be6647405c979835ed5a454c61" class="list-bold">
                <li id="data-uuid-ffcb064d1b4d43e18e020687b6321476" data-uuid="ffcb064d1b4d43e18e020687b6321476">
                    <p id="data-uuid-23dd106ec48a4a7397a364a51c8c0460" data-uuid="23dd106ec48a4a7397a364a51c8c0460">If you were a medical researcher, what other areas of the blood-clotting pathway would you target for inhibition to decrease the risks of stroke?</p>
                </li>
                <li id="data-uuid-cb8b9c2001214ac082355d0562e9c67a" data-uuid="cb8b9c2001214ac082355d0562e9c67a">
                    <p id="data-uuid-b9d9f2cad3db480eb4af2a997b9080e8" data-uuid="b9d9f2cad3db480eb4af2a997b9080e8">Under what medical conditions do you think that aspirin should not be used? Why?</p>
                </li>
            </ol>
        </section>
        <h2 id="data-uuid-97a4e341c9094be48ac018e852028986" data-uuid="97a4e341c9094be48ac018e852028986">Disorders Related to Blood Clotting</h2>
        <p id="data-uuid-ac666476aa734b68a9846a8760eebed7" data-uuid="ac666476aa734b68a9846a8760eebed7">An insufficient number of platelets is called <a href="../glossary.xhtml#key-thrombocytopenia"><dfn title="thrombocytopenia">thrombocytopenia</dfn></a><b>.</b> Thrombocytopenia is due to either low platelet production in bone marrow or increased breakdown of platelets outside the marrow. A number of conditions, including leukemia, can lead to thrombocytopenia. It can also be drug-induced. Symptoms include bruising, rash, and nosebleeds or bleeding in the mouth. Gastrointestinal bleeding and bleeding in the brain are possible complications.</p>
        <p id="data-uuid-ab7e0822f2d940f78ef0c9b8d9acbd12" data-uuid="ab7e0822f2d940f78ef0c9b8d9acbd12">If the lining of a blood vessel becomes roughened, a clot can form spontaneously inside an unbroken blood vessel. Most often, roughening occurs because an atherosclerotic plaque has formed (see <a href="../chapter05/ch05_reader_0.xhtml" class="link-inline">Chapter 5</a>). Rarely, the vessel lining is damaged during the placement of an intravenous tube. The spontaneous clot is called a <i>thrombus</i> (pl., thrombi) if it remains stationary inside the blood vessel. Sitting for long periods, as when traveling, can also cause thrombus formation. If the clot dislodges and travels in the blood, it is called an embolus.  If the embolus blocks a blood vessel, it may form a  <a href="../glossary.xhtml#key-thromboembolism"><dfn title="thromboembolism">thromboembolism</dfn></a><b>.</b> If left untreated, blood flow to the tissues can stop completely. Heart attack or stroke can result, as discussed in <a href="../chapter05/ch05_reader_0.xhtml" class="link-inline">Chapter 5</a>.</p>
        <p id="data-uuid-337daf2e94ec408cbe709f5e4b09ba6d" data-uuid="337daf2e94ec408cbe709f5e4b09ba6d"><a href="../glossary.xhtml#key-hemophilia"><dfn title="hemophilia">Hemophilia</dfn></a> is an inherited clotting disorder that causes a deficiency in a clotting factor. There are many forms of the disorder. Hemophilia A, caused by a deficiency of clotting factor VIII, is more likely to occur in boys than in girls. Hemophilia A is caused by an abnormal copy of the factor VIII production gene, found on the X chromosome. This hemophilia arises when a boy has an abnormal gene on his single X chromosome. Girls need only one normal gene between their two X chromosomes to make the normal amounts of clotting factor VIII (see <a href="../chapter21/ch21_reader_0.xhtml" class="link-inline">Chapter 21</a>). In hemophilia, the slightest bump can cause bleeding into the joints. Cartilage degeneration in the joints and absorption of underlying bone can follow. The most frequent cause of death is bleeding into the brain, with accompanying neurological damage. Regular injections of factor VIII can successfully treat the disease.</p>
        <section id="data-uuid-76cb097d0f514447b1ef10f501b69529" data-uuid="76cb097d0f514447b1ef10f501b69529" class="sidenote sidenote-application">
            <h4 id="data-uuid-33cab61cebb341cba829fe142a146743" data-uuid="33cab61cebb341cba829fe142a146743">Science in Your Life</h4>
            <h5 id="data-uuid-e7aeaea3dacc403db2b23d0ac7a2e163" data-uuid="e7aeaea3dacc403db2b23d0ac7a2e163">What are some other clotting disorders?</h5>
            <p id="data-uuid-349280b4ac9547ab936540aeb2bc1921" data-uuid="349280b4ac9547ab936540aeb2bc1921">In addition to hemophilia A, there are several other forms of clotting disorders. Hemophilia B, also called <i>Christmas disease</i> after the first person to be diagnosed with it (Stephen Christmas in 1952), is caused by a deficiency in clotting factor IX. Von Willebrand disease is caused by a deficiency in the gluelike protein that holds the platelets together at the site of a damaged blood vessel. All these disorders can be partially treated with injections of the missing proteins.</p>
        </section>
        <section id="data-uuid-cdbc686f96334d339c038c5ae7ad1f8c" data-uuid="cdbc686f96334d339c038c5ae7ad1f8c" class="sidenote sidenote-check">
            <h4 id="data-uuid-77052e1e5e374daf880741b84aeab8de" data-uuid="77052e1e5e374daf880741b84aeab8de">Check Your Progress 6.4</h4>
            <ol id="data-uuid-4a8397a674e4403b9fbe112829331a13" data-uuid="4a8397a674e4403b9fbe112829331a13" class="list-no-style custom-list">
                <li id="data-uuid-4fa7f96a252d44b299bd40547156d01c" data-uuid="4fa7f96a252d44b299bd40547156d01c">
                    <p id="data-uuid-f92bc4949b8048e3963e6b9a02e2044b" data-uuid="f92bc4949b8048e3963e6b9a02e2044b"><img src="../../assets/img/icon4.png" id="data-uuid-6db5d783a1264b84b51d77d37796fd85" data-uuid="6db5d783a1264b84b51d77d37796fd85" class="icon-list inline" />List the components of the blood that are involved in the formation of a blood clot.</p>
                </li>
                <li id="data-uuid-6e925614ea994193bd5cffcd66a3d7c0" data-uuid="6e925614ea994193bd5cffcd66a3d7c0">
                    <p id="data-uuid-ba76da9d30ca417987b7e97933449c7f" data-uuid="ba76da9d30ca417987b7e97933449c7f"><img src="../../assets/img/icon5.png" id="data-uuid-b4de3cbbc4df49a1b1bffe9561f410a6" data-uuid="b4de3cbbc4df49a1b1bffe9561f410a6" class="icon-list inline" />Describe the stages of blood clotting.</p>
                </li>
                <li id="data-uuid-ed2b474eaf8d44fbacf7e9674a7432d5" data-uuid="ed2b474eaf8d44fbacf7e9674a7432d5">
                    <p id="data-uuid-63068fae8d134907b84cb738c78f2813" data-uuid="63068fae8d134907b84cb738c78f2813"><img src="../../assets/img/icon6.png" id="data-uuid-fcf4c3b2c02d4250beb1cbef2a093412" data-uuid="fcf4c3b2c02d4250beb1cbef2a093412" class="icon-list inline" />Summarize a few of the blood-clotting disorders.</p>
                </li>
            </ol>
        </section>
        <section id="data-uuid-a8378538d2e14686b86d8c85ef181de3" data-uuid="a8378538d2e14686b86d8c85ef181de3" class="sidenote sidenote-connecting">
            <h4 id="data-uuid-79328a39ce83428ca9b0887d8e1ac10f" data-uuid="79328a39ce83428ca9b0887d8e1ac10f">Connecting the Concepts</h4>
            <p id="data-uuid-37c38a9954a44a51bd43c805657db5dd" data-uuid="37c38a9954a44a51bd43c805657db5dd">For more information on the disorders discussed in this section, refer to the following discussions:</p>
            <ul id="data-uuid-aca9cb72cf394f0babe1f3f1c70a0875" data-uuid="aca9cb72cf394f0babe1f3f1c70a0875" class="list-no-style list-no-indent">
                <li id="data-uuid-34cf58d5eb12475481975d2c62a18957" data-uuid="34cf58d5eb12475481975d2c62a18957">
                    <p id="data-uuid-3c33c71d36ce45388466ac73408ecda9" data-uuid="3c33c71d36ce45388466ac73408ecda9" class="no-indent"><a href="../chapter05/ch05_reader_7.xhtml#data-uuid-811f3e0e2ef849ada8c2331e9f515ce0" class="link-inline">Section 5.7</a> describes how blood clots relate to disorders of the cardiovascular system.</p>
                </li>
                <li id="data-uuid-52df262c84c34e748cad925419c041f2" data-uuid="52df262c84c34e748cad925419c041f2">
                    <p id="data-uuid-881933a4db7444efa2e1d07c8cad720d" data-uuid="881933a4db7444efa2e1d07c8cad720d" class="no-indent"><a href="../chapter21/ch21_reader_4.xhtml#data-uuid-d9d0a244012d41e5849368b9fb11c37c" class="link-inline">Section 21.4</a> explores the inheritance of hemophilia in the royal families of Europe.</p>
                </li>
            </ul>
        </section>
        <footer id="data-uuid-fdfb976720d741d889b8e20cd806e3b2" data-uuid="fdfb976720d741d889b8e20cd806e3b2">
        </footer>
    </body>
</html>